Literature DB >> 504551

Cardiovascular control in recently injured tetraplegics in spinal shock.

C J Mathias, N J Christensen, H L Frankel, J M Spalding.   

Abstract

Cardiovascular control was studied in five tetraplegic patients with physiologically complete cervical spinal cord transections. All had been injured less than two weeks previously and were in spinal shock. Blood pressure, heart rate, and plasma noradrenaline and adrenaline were measured at rest and during and after bladder stimulation and application of cold stimuli to skin below the level of the lesion. In three patients the cardiovascular responses to intravenously infused 1-noradrenaline and to the Valsalva manoeuvre were recorded. Measurements were also made in six chronic tetraplegic patients (in whom reflex spinal cord activity had returned) at rest, and during and after bladder stimulation, and in six normal subjects at rest. Average resting blood pressure in the recently injured tetraplegics was 130/57 (mean 81) mmHg, in the chronic tetraplegics 107/55 (mean 73) mmHg and in normal subjects 122/82 (mean 95) mmHg. Average resting heart rate was 64, 73 and 77 beats/min in the three groups respectively. Resting plasma noradrenaline and adrenaline levels in both the recently injured and chronic tetraplegics were lower than than in normal subjects. In the recently injured tetraplegics bladder stimulation caused minimal changes in blood pressure, heart rate and plasma noradrenaline and adrenaline levels. In the chronic tetraplegics similar stimulation caused marked hypertension, bradycardia and elevation in plasma noradrenaline but not adrenaline levels. Cold stimuli in the recently injured tetraplegics did not change blood pressure or heart rate. In the recently injured tetraplegics intravenous infusion of 1-noradrenaline resulted in greater elevation in blood pressure than normal. There was a decrease in heart rate. One patient was able to perform the Valsalva manoeuvre. His blood pressure responses were consistenly abnormal ('blocked' Valsalva).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 504551

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Non-invasive assessment of autonomic nervous system integrity in able-bodied and spinal cord-injured individuals.

Authors:  S Houtman; B Oeseburg; M T Hopman
Journal:  Clin Auton Res       Date:  1999-06       Impact factor: 4.435

2.  Pure distraction injury of T1-2 with quad fever.

Authors:  Jun-Yeong Seo; Chae-Moon Lim; Young-Hoon Kim; Kee-Yong Ha
Journal:  Eur Spine J       Date:  2017-08-03       Impact factor: 3.134

Review 3.  Autonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management.

Authors:  Khalid C Eldahan; Alexander G Rabchevsky
Journal:  Auton Neurosci       Date:  2017-05-08       Impact factor: 3.145

Review 4.  Acute complications of spinal cord injuries.

Authors:  Ellen Merete Hagen
Journal:  World J Orthop       Date:  2015-01-18

Review 5.  Clinical pharmacokinetics in patients with spinal cord injuries.

Authors:  J L Segal; S R Brunnemann
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

6.  Assessment of autonomic dysreflexia in patients with spinal cord injury.

Authors:  A Curt; B Nitsche; B Rodic; B Schurch; V Dietz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

7.  Bradycardia and cardiac arrest during tracheal suction--mechanisms in tetraplegic patients.

Authors:  C J Mathias
Journal:  Eur J Intensive Care Med       Date:  1976

Review 8.  Vascular dysfunctions following spinal cord injury.

Authors:  Constantin Popa; Florian Popa; Valentin Titus Grigorean; Gelu Onose; Aurelia Mihaela Sandu; Mihai Popescu; Gheorghe Burnei; Victor Strambu; Crina Sinescu
Journal:  J Med Life       Date:  2010 Jul-Sep

Review 9.  Cardiac dysfunctions following spinal cord injury.

Authors:  Valentin Titus Grigorean; Aurelia Mihaela Sandu; Mihai Popescu; Mihai Aurelian Iacobini; Rares Stoian; Catalin Neascu; Victor Strambu; Florian Popa
Journal:  J Med Life       Date:  2009 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.